Castle Biosciences (CSTL) Capital Leases (2023 - 2026)

Castle Biosciences (CSTL) posted Capital Leases of $264000.0 for Q2 2026, down 8.33% sequentially from $288000.0 in Q1 2026, and down 27.47% YoY from $364000.0 in Q2 2025.

Castle Biosciences (CSTL) Capital Leases (2023 - 2026) Analysis & Trends

Castle Biosciences has reported Capital Leases for 4 years, with the latest figure at $264000.0 in Q2 2026.

  • Quarterly Capital Leases fell 27.47% year-over-year to $264000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $264000.0 (down 27.47% YoY) and the FY2025 annual result came in at $314000.0, up 0.96% from the prior year.
  • Capital Leases fell to $264000.0 in Q2 2026 per CSTL's latest filing, from $288000.0 in the prior quarter.
  • Over five years, Capital Leases peaked at $364000.0 in Q2 2025 and troughed at $25000.0 in Q4 2023.
  • A 4-year average of $283400.0 and a median of $311500.0 in 2024 frame the typical range for Capital Leases.
  • The sharpest annual moves came in 2024 and 2026: Capital Leases surged 1144.0% in 2024, then dropped 27.47% in 2026.
  • Over 4 years, Capital Leases stood at $25000.0 in 2023, then soared by 1144.0% to $311000.0 in 2024, then rose by 0.96% to $314000.0 in 2025, then dropped by 15.92% to $264000.0 in 2026.
  • According to Business Quant data, Capital Leases over the past three periods registered $264000.0, $288000.0, and $314000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 213.40 Bn 209.33 Bn 8.34 Bn
2 Danaher 139.94 Bn 135.59 Bn 3.61 Bn
3 Idexx Laboratories 46.03 Bn 45.83 Bn 779.09 Mn
4 Agilent Technologies 39.69 Bn 37.88 Bn 990.00 Mn
5 Iqvia Holdings 39.32 Bn 37.24 Bn 1.44 Bn
6 Natera 38.47 Bn 37.37 Bn 696.04 Mn
7 Illumina 29.98 Bn 28.82 Bn 770.00 Mn
8 Mettler Toledo International 28.57 Bn 28.52 Bn 650.22 Mn
9 Quest Diagnostics 26.21 Bn 25.58 Bn 1.03 Bn
10 Castle Biosciences 923.37 Mn 656.55 Mn 79.85 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 264,000.00
Mar 31, 2026 288,000.00
Dec 31, 2025 314,000.00
Sep 30, 2025 339,000.00
Jun 30, 2025 364,000.00
Mar 31, 2025 328,000.00
Dec 31, 2024 311,000.00
Sep 30, 2024 289,000.00
Jun 30, 2024 312,000.00
Dec 31, 2023 25,000.00